Fear of Death Impacts Quality of Life-How Psychedelics Can Help

Researchers suggest that the benefits of psychedelic treatment are mediated by a reduction in death anxiety and existential distress.

-

While there is evidence for the therapeutic effects of psychedelics, there is less so on the front of how they produce such effects.1 One common thread between psychedelics and mental illness is underlying themes of death and death anxiety, which led Moreton and colleagues to speculate a potential mediating relationship. 

There are some psychopathologies for which the link to death anxiety may seem obvious; Panic attacks and panic disorder, for example, often involve a fear of heart attack or a sudden feeling of danger. Death anxiety also correlates with generalized anxiety disorder, social anxiety disorder, alcohol use disorder, and depressive disorder.2 Other research has found evidence for causality rooted in increased participant anxious and phobic behavior when primed with mortality salience or the awareness that death is inevitable.3-5

The underlying fear of death remains unaddressed by many existing mental health treatments, contributing to their continuation.6 While psychedelics have been found to reduce death anxiety, particularly in cases of terminal illness, there is less existing evidence on how they complete that goal.7

How Psychedelics Address Death Anxiety

To this end, Moreton et al. suggested a variation of the following five factors: (1) forced confrontations with mortality, (2) reduced focus on the self, (3) shifting metaphysical beliefs about human consciousness, (4) amplified religious faith, and (5) increased feelings of connectedness and meaning-making.1 The impact of any of these factors, much like the psychedelic experience itself, depends on the individual in question, as well as the set and setting of the session. The remainder of this article will break down each factor and how they are proposed to accomplish the hypothesized mediation. 

First, confronting death anxiety, much like exposure therapy, is thought to reduce the fear of dying over time. Moreton et al. proposed that psychedelics in particular provide a unique opportunity to confront fears of death, including the central role of ego dissolution.8 This living experience of death transcends traditional therapeutic exposure to mortality-related thoughts. Surrender to the psychedelic experience mimics that of surrender to near-death experiences, which have been found to provoke attitude changes and decrease fear of death.1,9,10

Second, Moreton et al. said that reduced focus on the self applies to mortality, as it is an egocentric concern. When psychedelics put the universe into perspective, the self and its concerns feel small.11

Third, when an individual experiences ego death, it introduces the idea that there is an existence beyond our known physical experience of life and death. Whether or not this is true or can be proven outside of the psychedelic session, it can lead to the belief that consciousness transcends death.12 This has been found to present as long-term agreement with statements such as, “death is a transition to something even greater than life” post-psilocybin treatment.13 Transcending death may reduce anxiety induced by death as a final destination, thereby combatting fear-based mental illness. 

Fourth, psychedelics often induce religious images. These can align with one’s religious beliefs or traditions other than their own. Individuals may feel that they saw God, or possibly feel they are God.14 Religiosity can, in turn, reduce effects of mortality salience, including distress.15-17 Given this effect, Moreton et al. hypothesized that psychedelic-induced religious experiences can buffer against distress related to the death anxiety that underlies many mental illnesses.

Fifth, and last, psychedelics promote a feeling of oneness with the universe, natural world, and fellow human beings.18-20 As with ego death, the idea that a person is not bound by their physical form and can live on through other sources resembles a “symbolic immortality.”21 It may seem likely that feeling connected to the world increases the meaning one assigns to different aspects of their life. In fact, people rate their psychedelic experience as among the most meaningful in their life.22,23 Furthermore, meaning in life acts as a buffer to death anxiety and effects of mortality salience.24-26

Conclusion

As psychedelic research evolves, scientists will continue to study how they invoke beneficial therapeutic effects. The relation of death anxiety to both psychedelics and mental health has led researchers to postulate it as a possible mechanism through which the two interact; however, there is a lack of experiments testing death anxiety as a causal variable. The authors, therefore, urge that their presented hypothesis and reasoning justify future research to this end. Regardless, psychedelics remain complex and multifaceted substances, and these suggestions are to be studied in accordance with other potential proposed mechanisms, at least until research further clarifies the picture.

Sabrina Eisenberg

Sabrina is a doctoral student at the University of South Florida. She is interested in studying personality and transformative experiences influence relationships.

Comments

2 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
Billy Reynard-Bowness
2 days ago

Fear of Death / Thanatophobia support group:
http://www.facebook.com/groups/deathanxiety

Neville S J O'Neill
1 hour ago

really helpful article.thank you, got identification and connection with the sentiments

    References
  1. Moreton SG, Szalla L, Menzies RE, Arena AF. Embedding existential psychology within psychedelic science: reduced death anxiety as a mediator of the therapeutic effects of psychedelics. Psychopharmacology. 2020 Jan; 237(1): 21-32. https://doi.org/10.1007/s00213-019-05391-0
  2. Menzies RE, Sharpe L, Dar-Nimrod I. The relationship between death anxiety and severity of mental illnesses. British Journal of Clinical Psychology. 2019 Nov; 58(4): 452-467. doi:10.1111/bjc.12229
  3. Strachan E, Schimel J, Arndt J, et al. Terror mismanagement: evidence that mortality salience exacerbates phobic and compulsive behaviors. Personality and Social Psychology Bulletin. 2007;33(8):1137-1151. doi:10.1177/0146167207303018
  4. Finch EC, Iverach L, Menzies RG, Jones M. Terror mismanagement: evidence that mortality salience exacerbates attentional bias in social anxiety. Cognition & Emotion. 2016;30(7):1370-1379. doi:10.1080/02699931.2015.1065794
  5. Menzies RE, Dar-Nimrod I. Death anxiety and its relationship with obsessive-compulsive disorder. Journal of Abnormal Psychology. 2017;126(4):367-367. http://dx.doi.org/10.1037/abn0000263
  6. Iverach L, Menzies RG, Menzies RE. Death anxiety and its role in psychopathology: reviewing the status of a transdiagnostic construct. Clinical Psychology Review. 2014;34(7):580-593. doi:10.1016/j.cpr.2014.09.002
  7. Reiche S, Hermle L, Gutwinski S, Jungaberle H, Gasser P, Majić T. Serotonergic hallucinogens in the treatment of anxiety and depression in patients suffering from a life-threatening disease: a systematic review. Progress in neuro-psychopharmacology & biological psychiatry. 2018;81:1-10. doi:10.1016/j.pnpbp.2017.09.012
  8. Leary T, Metzner R, Albert R. Psychedelic Experience:A Manual Based on the Tibetan Book of the Dead. University Books; 1964
  9. Noyes R Jr. Attitude change following near-death experiences. Psychiatry. 1980;43(3):234-242. doi:10.1080/00332747.1980.11024070
  10. Noyes R. The human experience of death or, what can we learn from near-death experiences? Omega. 1983;13(3):251-259. doi:10.2190/DKHY-N1C3-XXA0-G7M5
  11. Piff PK, Dietze P, Feinberg M, Stancato DM, Keltner D. Awe, the small self, and prosocial behavior. Journal of personality and social psychology. 2015;108(6):883-899. doi:10.1037/pspi0000018
  12. Pahnke WN. The Psychedelic Mystical Experience in the Human Encounter with Death. Harvard Theological Review. 1969;62(1):1-21. doi:10.1017/S0017816000027577
  13. Griffiths RR, Johnson MW, Richards WA, Richards BD, Mccann U, Jesse R. Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects. Psychopharmacology. 2011;218(4):649-665. doi:10.1007/s00213-011-2358-5
  14. Fadiman J. The Psychedelic Explorer’s Guide. Park Street Press; 2011.
  15. Dechesne M, Pyszczynski T, Arndt J, Ransom S. Literal and symbolic immortality: the effect of evidence of literal immortality on self-esteem striving in response to mortality salience. Journal of Personality and Social Psychology. 2003;84(4):722-737. doi:10.1037/0022-3514.84.4.722
  16. Heflick NA, Goldenberg JL. No atheists in foxholes: arguments for (but not against) afterlife belief buffers mortality salience effects for atheists. The British Journal of Social Psychology. 2012;51(2):385-392. doi:10.1111/j.2044-8309.2011.02058.x
  17. Jonas E, Fischer P. Terror management and religion: evidence that intrinsic religiousness mitigates worldview defense following mortality salience. Journal of Personality and Social Psychology. 2006;91(3):553-553. doi:10.1037/0022-3514.91.3.553
  18. Pollan M. How to Change Your Mind : What the New Science of Psychedelics Teaches Us About Consciousness, Dying, Addiction, Depression, and Transcendence. London: Penguin Books; 2019.
  19. Carhart-Harris RL, Erritzoe D, Haijen E, Kaelen M, Watts R. Psychedelics and connectedness. Psychopharmacology. 2018;235(2):547-550. doi:10.1007/s00213-017-4701-y
  20. Griffiths RR, Johnson MW, Richards WA, et al. Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors. Journal of Psychopharmacology. 2018;32(1):49-69. doi:10.1177/0269881117731279
  21. Lifton RJ. The Broken Connection : On Death and the Continuity of Life. New York: Simon and Schuster; 1979.
  22. Griffiths RR, Richards WA, Johnson MW, McCann UD, Jesse R. Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later. Journal of Psychopharmacology. 2008;22(6):621-632. doi:10.1177/0269881108094300
  23. Griffiths RR, Richards WA, McCann U, Jesse R. Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance. Psychopharmacology. 2006;187(3):268-283. doi:10.1007/s00213-006-0457-5
  24. Drolet J-L. Transcending death during early adulthood: symbolic immortality, death anxiety, and purpose in life. Journal of Clinical Psychology. 1990;46(2):148-148. doi:10.1002/1097-4679(199003)46:2<148::aid-jclp2270460205>3.0.co;2-t
  25. Rieger D, Frischlich L, Hogden F, Kauf R, Schramm K, Tappe Erzsébet. Appreciation in the face of death: meaningful films buffer against death-related anxiety. Journal of Communication. 2015;65(2):351-372. doi:10.1111/jcom.12152
  26. Routledge C, Juhl J. When death thoughts lead to death fears: mortality salience increases death anxiety for individuals who lack meaning in life. Cognition & Emotion. 2010;24(5):848-854. doi:10.1080/02699930902847144